Primary infliximab failure in pediatric colonic inflammatory bowel disease: Development of a proteomics predictive model using a prospective Canadian cohort

Inflammatory Bowel Disease

Persistence and safety of subcutaneous infliximab up to 1 year after switching from intravenous infliximab in pediatric inflammatory bowel disease: a multicenter real-world cohort study

Inflamm Bowel Dis

Boute EH, Gianolio L, Mahmmod S, Pochesci S, Armstrong K, Henderson P, Wilson DC, de Ridder L, Russell RK, Escher JC

doi: 10.1093/ibd/izaf335

Inflammatory Bowel Disease

Development and validation of a predictive model for early failure of biological therapy in perianal fistulizing Crohn's disease based on three-dimensional transrectal ultrasound

Inflamm Bowel Dis

Ding SS, Liu C, Zhang GQ, Ren WW, Zhao H, Zhang Q, Yin HQ, Sun LP, Xu HX

doi: 10.1093/ibd/izag048

Inflammatory Bowel Disease

Tonsillectomy and the Risk of Inflammatory Bowel Disease: A Retrospective Cohort Study Using Real-World US Data

Inflamm Bowel Dis

Guo JY, Wu MC, Wang YH, Lin CC, Wei JC

doi: 10.1093/ibd/izaf306

Further Publications

Use of medications to treat inflammatory bowel diseases before and during pregnancy in Switzerland between 2012 and 2019: an observational study using the claims-based MAMA cohort

BMC Gastroenterol

Gerbier E, Abolhassani N, Dupuis M, Oppliger B, Kandhasamy S, Favre G, Maisonneuve E, Winterfeld U, Legardeur H, Ceulemans M, Baud D, Spoendlin J, Panchaud A

doi: 10.1186/s12876-026-04925-z

COMMENTED

Inflammatory Bowel DiseaseFurther Publications

A Prospective Interventional Study to Evaluate the Effect of Hypoxia on Healthy Volunteers and Patients With Inflammatory Bowel Disease: The Altitude Inflammatory Bowel Disease Study

★ 3 Recommended and commented by Prof. Dr Stephan Vavricka, Faculty Member

Am J Gastroenterol

Vavricka SR, Zeitz J, Madanchi M, Ruiz PA, Biedermann L, Morsy Y, Yilmaz B, Scharl M, Scharl S, Gassmann M, Lutz TA, Kunz A, Bron D, Misselwitz B, MacPherson AJ, Rogler G, Greuter T

doi: 10.14309/ajg.0000000000003888

RECOMMENDED

Inflammatory Bowel Disease

Prediction of inflammatory bowel disease based on early life risk factors in a population-based cohort

★ 1 Recommended by Prof. Dr Stephan Vavricka, Faculty Member

Clin Gastroenterol Hepatol

Agrawal M, Hansen AV, Julsgaard M, Colombel JF, Jess T

doi: 10.1016/j.cgh.2026.01.034

Inflammatory Bowel Disease

Meta-analysis: safety and efficacy of ustekinumab in pediatric inflammatory bowel disease patients with anti-TNF failure

BMC Gastroenterol

Heng Z, Zhan L, Zhang Y, Xu K, Song M, Zhao K, Jahan MS, Akter MF, Lu P, Ji Y, Liu Y

doi: 10.1186/s12876-026-05078-9

ColonoscopyInflammatory Bowel Disease

Higher Colonic Tissue Drug Concentrations of Subcutaneous Compared to Intravenous Administration of Infliximab Therapy in Patients With Inflammatory Bowel Disease

United European Gastroenterol J

Roblin X, Nancey S, Papamichael K, Mechi F, Ouvrier-Buffet J, Charlois AL, Peaucelle AS, Bastide L, Berger AA, Barrau M, Cheifetz AS, Duru G, Paul S

doi: 10.1002/ueg2.70207

Further Publications

Disorders of Gut-Brain Interaction like symptoms in Children with Inflammatory Bowel Disease: A Multicenter Prospective Study from the Pediatric IBD Porto Group of the ESPGHAN

Am J Gastroenterol

Martinelli M, Salomone S, Strisciuglio C, Zellos A, Romano C, Dipasquale V, Bramuzzo M, Lega S, Aloi M, D'Arcangelo G, Rodríguez-Belvís MV, Colucci A, Miele E, Staiano A, Eleftheria R

doi: 10.14309/ajg.0000000000004140

Related content

Persistence and safety of subcutaneous infliximab up to 1 year after switching from intravenous infliximab in pediatric inflammatory bowel disease: a multicenter real-world cohort study

Development and validation of a predictive model for early failure of biological therapy in perianal fistulizing Crohn's disease based on three-dimensional transrectal ultrasound

Tonsillectomy and the Risk of Inflammatory Bowel Disease: A Retrospective Cohort Study Using Real-World US Data

Use of medications to treat inflammatory bowel diseases before and during pregnancy in Switzerland between 2012 and 2019: an observational study using the claims-based MAMA cohort

A Prospective Interventional Study to Evaluate the Effect of Hypoxia on Healthy Volunteers and Patients With Inflammatory Bowel Disease: The Altitude Inflammatory Bowel Disease Study

Prediction of inflammatory bowel disease based on early life risk factors in a population-based cohort

Meta-analysis: safety and efficacy of ustekinumab in pediatric inflammatory bowel disease patients with anti-TNF failure

Higher Colonic Tissue Drug Concentrations of Subcutaneous Compared to Intravenous Administration of Infliximab Therapy in Patients With Inflammatory Bowel Disease

Disorders of Gut-Brain Interaction like symptoms in Children with Inflammatory Bowel Disease: A Multicenter Prospective Study from the Pediatric IBD Porto Group of the ESPGHAN